Literature DB >> 1373151

Phenotypic expression of integrin membrane receptors on spontaneously proliferating CD8 cells in human T-lymphotropic virus type II (HTLV-II)-infected individuals.

R B Lal1, D L Rudolph, T Rowe, T M Folks.   

Abstract

Spontaneous lymphocyte proliferation in the absence of exogenous stimulators was examined in asymptomatic HTLV-II-seropositive (n = 12) and seronegative individuals (n = 16). Mean spontaneous lymphocytic proliferation significantly increased on day 8 postculture in HTLV-II-infected individuals (5762 +/- 899 cpm) compared with normal controls (2034 +/- 925 cpm, P less than 0.01). The proliferating cells in infected individuals were predominantly T cells; neither B cells nor monocytes demonstrated any proliferation. Phenotypic analysis of cultured cells from individuals with HTLV-II infection demonstrated differential expression of integrin molecules as defined by anti-CD29 and anti-S6F1 (42.8 +/- 4.2 and 39.6 +/- 5.9%, respectively) on CD8 cells, as compared with day 0 peripheral blood mononuclear cells (PBMC) from infected individuals (19.7 +/- 3.5 and 19.9 +/- 1.9%, respectively) or normal controls (12.9 +/- 3.1 and 11.5 +/- 2.5%, respectively; P less than 0.001 for both comparisons). These CD8+ cells did not express CD16 or CD11b. The culture supernatants derived from the spontaneously proliferating cells had significantly increased levels of sCD8 and sCD25 (765 +/- 180 and 1805 +/- 320 U/ml, respectively) compared with those from normal controls (222 +/- 120 and 305 +/- 90 U/ml, respectively; P less than 0.01). Furthermore, culture supernatants derived from spontaneously proliferating PBMC from HTLV-II-infected individuals had no detectable levels of HTLV antigen and did not stimulate proliferation of PBMC from normal donors. These results suggest that the spontaneous proliferation in HTLV-II asymptomatic carriers is due to expansion of CD8 cells expressing integrin receptors which may serve as costimulatory molecules for their activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373151     DOI: 10.1007/bf00918136

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  44 in total

Review 1.  The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease.

Authors:  A Manns; W A Blattner
Journal:  Transfusion       Date:  1991-01       Impact factor: 3.157

Review 2.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Spontaneous lymphocyte proliferation in symptom-free HTLV-I positive Jamaicans.

Authors:  A Krämer; S Jacobson; J F Reuben; E L Murphy; S Z Wiktor; B Cranston; J P Figueroa; B Hanchard; D McFarlin; W A Blattner
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

4.  Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression.

Authors:  W C Greene; W J Leonard; Y Wano; P B Svetlik; N J Peffer; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Science       Date:  1986-05-16       Impact factor: 47.728

Review 5.  Regulation of transmembrane signaling by receptor phosphorylation.

Authors:  D R Sibley; J L Benovic; M G Caron; R J Lefkowitz
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

6.  Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers.

Authors:  Y Tanaka; S Oda; K Nagata; N Mori; H Sakamoto; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

7.  CD11a/CD18 (LFA-1) epitopes involved in syncytium formation among CD4+ T-cells following cell free HIV-1 infection.

Authors:  J Goudsmit; L Smit
Journal:  Viral Immunol       Date:  1990       Impact factor: 2.257

8.  Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation.

Authors:  J E Hildreth; R J Orentas
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

9.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

10.  Spontaneous T cell proliferation and release of soluble interleukin-2 receptors in patients with HTLV-I-associated myelopathy.

Authors:  M Matsumoto; M Sugimoto; H Nakashima; F Imamura; O Kawano; E Uyama; K Takatsu; S Araki
Journal:  Am J Trop Med Hyg       Date:  1990-04       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.